Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 24465475)


The seroepidemiology of Haemophilus influenzae type b prior to introduction of an immunization programme in Kathmandu, Nepal.

Marshall AS, Barker CI, Pulickal AS, Kibwana E, Gautam SC, Clutterbuck EA, Thorson SM, Shrestha S, Adhikari N, Pollard AJ, Kelly DF.

PLoS One. 2014 Jan 22;9(1):e85055. doi: 10.1371/journal.pone.0085055. eCollection 2014.


Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009.

Ladhani S, Ramsay M, Flood J, Campbell H, Slack M, Pebody R, Findlow J, Newton E, Wilding M, Warrington R, Crawford H, Min S, Gray K, Martin S, Frankland S, Bokuvha N, Laher G, Borrow R.

Euro Surveill. 2012 Nov 15;17(46). pii: 20313.


Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.

Kelly DF, Moxon ER, Yu LM, Pollard AJ.

Clin Vaccine Immunol. 2009 Feb;16(2):246-52. doi: 10.1128/CVI.00023-08. Epub 2008 Sep 10.


Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.

Ishiwada N, Honda Y, Tanaka J, Hishiki H, Kohno Y.

J Infect Chemother. 2011 Jun;17(3):397-400. doi: 10.1007/s10156-010-0186-x. Epub 2010 Dec 25.


Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.

Lee YC, Kelly DF, Yu LM, Slack MP, Booy R, Heath PT, Siegrist CA, Moxon RE, Pollard AJ.

Clin Infect Dis. 2008 Jan 15;46(2):186-92. doi: 10.1086/524668.


Serological protection induced by Haemophilus influenzae Type B conjugate vaccine in Mexican children: is a booster dose of the vaccine needed?

Rodriguez RS, Mascarenas C, Conde-Glez CJ, Inostroza J, Villanueva S, Velázquez ME, Sánchez-Alemán MA, Echániz G.

Clin Vaccine Immunol. 2010 Oct;17(10):1639-41. doi: 10.1128/CVI.00249-10. Epub 2010 Aug 18.


Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.

Ladhani S, Heath PT, Slack MP, McIntyre PB, Diez-Domingo J, Campos J, Dagan R, Ramsay ME; Participants of the European Union Invasive Bacterial Infections Surveillance Network.

Clin Microbiol Infect. 2010 Jul;16(7):948-54. doi: 10.1111/j.1469-0691.2009.02945.x. Epub 2009 Nov 4.


Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine.

Mawas F, Peyre M, Beignon AS, Frost L, Del Giudice G, Rappuoli R, Muller S, Sesardic D, Partidos CD.

J Infect Dis. 2004 Sep 15;190(6):1177-82. Epub 2004 Aug 11.


Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.

Sow SO, Tapia MD, Diallo S, Keita MM, Sylla M, Onwuchekwa U, Pasetti MF, Kotloff KL, Levine MM.

Am J Trop Med Hyg. 2009 Jun;80(6):1033-8.


Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.

Heath PT, Booy R, Azzopardi HJ, Slack MP, Bowen-Morris J, Griffiths H, Ramsay ME, Deeks JJ, Moxon ER.

JAMA. 2000 Nov 8;284(18):2334-40.


Evaluation of haemophilus influenzae type b vaccine for routine immunization in Nepali infants.

Metz JA, Hanieh S, Pradhan R, Joshi A, Shakya D, Shrestha L, Shrestha A, Upadhyay B, Kelly SC, John TM, Maharjan BD, Yu LM, Omar O, Borrow R, Findlow J, Kelly DF, Thorson SM, Adhikari N, Murdoch DR, Pollard AJ.

Pediatr Infect Dis J. 2012 Apr;31(4):e66-72. doi: 10.1097/INF.0b013e31824a9c37.


Haemophilus influenzae type b reemergence after combination immunization.

Johnson NG, Ruggeberg JU, Balfour GF, Lee YC, Liddy H, Irving D, Sheldon J, Slack MP, Pollard AJ, Heath PT.

Emerg Infect Dis. 2006 Jun;12(6):937-41.


Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom.

Ladhani S, Heath PT, Ramsay ME, Slack MP, Kibwana E, Pollard AJ, Booy R.

Clin Infect Dis. 2009 Aug 1;49(3):372-80. doi: 10.1086/600292.


Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.

Jelonek MT, Chang SJ, Chiu CY, Park MK, Nahm MH, Ward JI.

Infect Immun. 1993 Dec;61(12):5345-50.


Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.

Santosham M, Englund JA, McInnes P, Croll J, Thompson CM, Croll L, Glezen WP, Siber GR.

Pediatr Infect Dis J. 2001 Oct;20(10):931-40.


Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.

Berrington JE, Cant AJ, Matthews JN, O'Keeffe M, Spickett GP, Fenton AC.

Pediatrics. 2006 Apr;117(4):e717-24. Epub 2006 Mar 20.


Do we need a booster of Hib vaccine after primary vaccination? A study on anti-Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease.

Hallander HO, Lepp T, Ljungman M, Netterlid E, Andersson M.

APMIS. 2010 Nov;118(11):878-87. doi: 10.1111/j.1600-0463.2010.02674.x. Epub 2010 Sep 2.


Bacteria, polysaccharides, vaccines and boosting: measuring and maintaining population immunity.

Goldblatt D.

Arch Dis Child. 2008 Aug;93(8):646-7. doi: 10.1136/adc.2007.133124. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk